Next, we determined the accuracy of CTNNB1 32–37 qPCR assay by detecting mutations in liver tissue DNA from patients with hepatitis (n = 35), cirrhosis (n = 35), or HCC (n = 73) and validating by Sanger sequencing. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.